Background. Surveys of Behç et's disease (BD) have shown substantial geographic variations in prevalence, but some of these differences may result from methodological inconsistencies. This meta-analysis explored the effect of geographic location and study methodology on the prevalence of BD.
The geospatial distribution of BD may hold important clues to the aetiology of BD. The current understanding is that BD occurs in many populations across the world but that it is much more common in countries along the Silk Road and seemingly rare in northern European countries. Epidemiological surveys have reported remarkable variations in prevalence proportions that differ at extremes by a factor of 1000 [2] . The large differences in the reported occurrence strongly suggest the intervention of geography-specific aetiological factors and point to a major role of yet unknown environmental risk determinants. Indeed, genetic differences across ethnic/racial groups are not likely strong enough to explain extreme variations in the frequencies of complex diseases [3] . Thus, differences in frequencies of diseases may reflect geographic variations and also methodological inconsistencies, changes over time or random fluctuation. Metaanalysis is increasingly being used to summarize prevalence data for diseases [4, 5] with the aim of exploring the sources of variations in disease frequency and assessing their effect magnitudes [6] .
Here we report on our meta-analysis of the effect of geographic location and methodological and other study characteristics on the global prevalence of BD.
Methods
We performed a systematic literature review and metaanalysis that followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statements [7] . Deviations from these statements, when deemed inappropriate to the context of comprehensively summarizing prevalence proportions, are specified in the corresponding Methods sections.
Systematic literature review process
We searched Medline (from 1960 onwards) and EMBASE (from 1950 onwards) for reports of population-based studies of the prevalence of BD by using combinations of the MeSH term Behç et syndrome with incidence or prevalence, with no restrictions on language or publication date. The main literature search was performed in March 2015 and updated in June 2016. We also handsearched reference lists of relevant publications, review articles, conference proceedings from international BD meetings and textbooks by using a snowballing strategy. We included peer-reviewed publications (full original articles and letters to the editor) and grey literature (e.g. conference abstracts, conference proceedings, edited book chapters and dissertations) since the results of meta-analyses are considered more accurate when also including literature not published in peer-reviewed journals [8] . Publications written in languages not mastered by any of the authors were analysed with the help of native speakers.
To be included in the meta-analysis, studies had to report a point estimate for BD prevalence and had to have a population-based survey design defined by a study population that could be considered representative of the general population. Studies were eligible if the reported estimate referred to only adult populations; surveys focusing exclusively on paediatric populations were not eligible. Pre-specified eligibility criteria also included the requirement that the publication had to provide the number of identified prevalent BD cases to guarantee that the reported prevalence proportion was based on an exact case count and not simply a subjective approximation; consequently, we excluded studies providing prevalence estimates but not the number of prevalent BD cases. One author (C.M.) reviewed the titles and abstracts of the studies identified and selected potentially eligible publications for full assessment.
Data extraction
Two authors (K.D. and C.M.) independently extracted the following data from all studies selected by using a studyspecific data extraction form: publication reference (name of first author, study period), language and type; geographic location of the study area; study period; age limits of the study population (if relevant); study methodology; criteria used to classify BD; number of prevalent cases (numerator); size of the study population (denominator) and prevalence estimates. For studies involving multi-ethnic populations living in the same study area, the numbers extracted were for the entire population and not those for only the indigenous subpopulation. For studies not reporting the denominator population size, we first attempted to obtain that information by sending emails to the corresponding authors. If this was unsuccessful, the denominator population was back-calculated by using the reported numerators and crude prevalence proportions. If a study provided only a standardized prevalence proportion (with reference to the age or agesex distribution of an external standard population), this figure was used for the back-calculation.
According to the case-finding strategy used, two main categories of study design were discerned: census and sample surveys. Census surveys were defined as investigations in which cases were found indirectly in one or more sources of medical information (e.g. hospital data, ad hoc surveys among community physicians, registries, memberships in patient support groups). Sample surveys were defined as studies in which cases were identified by directly approaching individuals (e.g. telephone interviews, household visits). The more intricate process of sample surveys involves the approach being applied to relatively small population samples selected from the background populations. Sample surveys were further characterized by whether they used a multistage algorithm, which typically includes a physical examination to identify previously undiagnosed BD. The reference type was classified as peer-reviewed publications or grey literature.
The extracted data were cross-checked and betweenassessor disagreements were resolved by discussion and, when necessary, with a third author (A.M.). No formal quality assessment was performed because of the lack of consensus and specific instruments for grading the quality of studies determining the frequency of human diseases in the general population [9] .
Meta-analyses of prevalence data and metaregression Prevalence proportions, expressed as the number of BD cases per 100 000 inhabitants, were calculated for each study by dividing the number of prevalent BD cases by the size of the study population. The prevalence proportions were log transformed and included in a random effects meta-analysis, assuming a Poisson normal distribution to calculate pooled prevalence proportions and 95% CIs [10] . For studies with prevalence proportions of zero, we replaced the numerator counts of zero with 0.5 to allow for taking the log transformation. Inverse-variance weighting was used for data pooling and the between-study variance (t 2 ) was estimated by maximum likelihood estimators [11] . Pooled proportions and 95% CIs were then back-transformed to the original scale. Statistical heterogeneity of estimates among studies was quantified by using the I 2 index and classified as low (25%), moderate (50%) or high (75%) [12] . Publication bias was not examined because it was deemed irrelevant in the framework of summarizing descriptive data on the frequency of a disease.
To explore potential sources of between-study heterogeneity, we performed subgroup analyses and mixed-effects Poisson metaregression [13] . Pre-specified stratification variables were geographic study area (according to common geographic delineations), study design (census vs sample survey), criteria used to classify BD (International Study Group criteria [14] or not), study period (classified in four periods with approximately equal numbers of studies) and reference type (peer-reviewed publications vs grey literature). Because the study period was not consistently reported in publications, we used year of publication as a proxy. Multivariable Poisson regression analysis was used to test the association of explanatory covariates and BD prevalence after adjustment for potential confounders.
Meta-analysis and metaregression were performed using the metafor package of the statistical software R (R Project for Statistical Computing, Vienna, Austria).
Results

Literature search
The flow of study selection is shown in Fig. 1 . The electronic database search yielded 1451 citations; 12 additional publications were found by handsearching; 50 potentially eligible studies were identified [1564] . Five studies were excluded, three due to non-reporting of numerator data [27, 30, 51] and two that included replicate data [29, 60] . From one study that provided prevalence data for two study populations, with one nested inside of the other, we selected the data for the smaller population for which more detailed information was provided in the publication [53] . Therefore, all pooled analyses pertained to 45 study populations reported in 45 publications [1526, 28, 3150, 5259, 6164].
Characteristics of identified prevalence surveys
The 45 studies were published between 1974 [61] and 2015 [25, 39] . In six studies, BD was one of a number of diseases for which prevalence proportions were estimated [20, 23, 45, 58, 59, 62] . The studies covered 22 countries, grouped into six geographic areas: Asia (5 studies) [45, 50, 58, 61, 62] Caribbean Islands (4 studies) [21, 31, 35, 44] , northern Europe (9 studies) [24, 34, 3840, 48, 53, 55, 64] , southern Europe (8 studies) [22, 26, 33, 47, 52, 54, 56, 57] and Turkey (8 studies) [1820, 25, 32, 36, 59, 63] . Overall, 26 studies used the International Study Group classification criteria for BD and the remaining used varied established classification criteria or study-specific definitions. Tables 1 and 2 summarize the main characteristics of the 45 studies retained for analyses, the 28 studies based on a census methodology and the 17 studies based on a sample methodology. Among the 28 census surveys, case-finding relied on a single source of information in 20 studies and multiple sources in 8 (Table 1) . Among the 17 sample surveys, 15 used a multistage approach with sequential screening algorithms to identify people with both previously diagnosed or undiagnosed BD.
Summary results for prevalence
The study-specific prevalence proportions (per 100 000 inhabitants) across the 45 studies ranged from 0.1 (95% CI 0, 1.0) [35] to 479.8 (272.9, 843.7) [46] (Fig. 2) . Table 3 shows the results of the pooled prevalence proportions (per 100 000 inhabitants) for all studies combined and within subgroups. The pooled overall prevalence proportion (per 100 000 inhabitants) was 10.3 (95% CI 6.1, 17.7) and featured high between-study heterogeneity (I 2 = 99.9%) (Fig. 2) Between-study heterogeneity remained mostly high within geographic strata. Subgroup analyses of the effect of study design showed striking differences in pooled BD prevalence proportions (per 100 000 inhabitants), with estimates of 3.6 (95% CI 2.6, 5.1) for census surveys vs 82.5 (95% CI 47.3, 143.7) for sample surveys. In light of the unequal geographic distributions of census and sample surveys and to rule out that the magnitude of differences in the computed BD prevalence proportions was artificially inflated by confounding with geographic location, we computed prevalence proportions within the areas where studies with either design were undertaken. The analyses of Middle East and Asian studies suggested an 12-fold greater pooled BD prevalence for sample surveys than census surveys (Table 3) .
Further stratification of census surveys by whether casefinding occurred via single or multiple sources of medical information revealed similar pooled prevalence proportions across strata (data not shown). Classification criteria, study period or reference type had a negligible impact on BD prevalence (Table 3) . Between-study heterogeneity remained high in all subgroups.
Metaregression analyses of prevalence proportions
Univariate metaregression analyses confirmed the strong effect of geographic area and study design on the pooled BD prevalence (both P < 0.0001). To separate the respective effects of geographic area and study design on BD prevalence, we performed multivariate metaregression analyses including both predictor variables (Table 4) . When adjusting for geographic area, study design consistently predicted BD prevalence in the analyses of all studies (P = 0.0001) or only studies from the Middle East and Asia where both census and sample surveys were undertaken (P = 0.0003). In contrast, when adjusting for study design, the effect of geographic area did not significantly predict BD prevalence in the analyses of all geographic areas combined (P = 0.089) or the Middle East and Asian studies (P = 0.240). In addition, we studied the effect of geographic area for studies using census or sample methodologies. Geographic area did not significantly predict BD prevalence in studies with census surveys (P = 0.127) or sample surveys (P = 0.153).
Classification criteria, study period and reference type had no significant effect on BD prevalence proportions in unadjusted analyses and mostly no significant effect after adjustment for geographic area and/or study design.
Discussion
Our analyses pooled prevalence data for BD reported from 45 population-based surveys. The overall prevalence estimate of 10.3/100 000 inhabitants should be interpreted as the best global summary estimate of available frequency data for BD from countries and areas where such studies were undertaken. More importantly, our findings suggest that in addition to geographic location, the case-finding methodology used to generate prevalence estimates strongly affected the outcome of such studies. Conversely, the criteria used to classify BD had no perceptible impact on disease prevalence estimates, which corroborates the only marginally different performance characteristics of the various classification systems for BD [65] .
Meta-analysis of prevalence data offers the opportunity to disentangle true variations in disease frequency from the effects of confounders, but it also has some conceptual challenges [5] . In particular, different mathematical methods have been suggested to transform individual prevalence estimates (i.e. log or arcsine) and eventually summarize them [10] . Some meta-analyses of prevalence data used negative binomial models, which is essentially a Poisson model with a gamma-distributed random effect [66] . However, we used a Poisson normal model because the assumed normal distribution of the random effects component better suits the use of between-study heterogeneity statistics such as I 2 . Even though these choices likely result in slight differences in absolute estimates, they should not substantially bias the relative differences across subgroups and thus our conclusions in terms of the factors predicting BD prevalence. As anticipated, the analyses showed geographic disparities in BD prevalence. The pooled prevalence estimate of 120/100 000 for Turkey, handled as a standalone geographic area because of the large number of studies (n = 8) identified for this single country, indicates a 4-to 57-fold higher prevalence in Turkey than in any other area. The results also showed a south to north decreasing frequency in Europe, which reinforces the rare occurrence of BD in northern Europeans. Because several of the northern European studies analysed multi-ethnic populations in which non-European migrants accounted for disproportionately high numbers among all identified cases [34, 39, 48, 53, 64] , the occurrence of BD in people of genuine northern European background must be even lower than indicated by our estimate. Pertinently, our study estimated a 22-fold higher pooled BD prevalence for sample surveys, at times also called field [63] or population surveys [4] , than those based on a census methodology. To determine whether this result was confounded by geographic variations, we performed
Pooled estimates are shown for all studies combined and within subgroups of studies involving census or sample surveys. The dashed vertical line represents the summary prevalence proportion for all studies combined.
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Several factors potentially explain the greater estimates with sample vs census surveys. By approaching people individually, sample surveys circumvent the risk of undercounting inherent to census surveys, which collect cases indirectly from sources of medical information that may provide incomplete data. As well, sample surveys often involve active screening for disease. Among the 14 sample surveys with active screening for BD, 5 provided the number of newly identified cases [18, 25, 36, 41, 63] and revealed that up to 95% of the identified cases were previously not known to have BD. The estimates from sample surveys may be further inflated by responder bias and skewed sampling of populations with demographic or other characteristics that bear an increased likelihood of having BD. Age and gender standardization or use of responders only as a denominator for prevalence calculations, which may prevent some of these biases, were only rarely implemented [20, 45] .
The finding that prevalence proportions derived from census and sample surveys may not be directly comparable is of importance for illnesses other than BD. Indeed, recent data suggest that sample surveys result in 10-to 20-fold higher prevalence estimates for primary Sjö gren's syndrome as compared with census surveys [4, 67] . The magnitude of difference in the estimates produced by census and sample surveys cannot be established as a general rule. In the context of BD, an indication is provided by the 12-fold difference found within the Asian and Middle Eastern studies, but this estimate is not implicitly generalizable to other areas or other diseases.
The fact that all BD studies from high-prevalence Turkey and none from low-prevalence Europe used a sample approach suggests that the true geographic differences in BD prevalence might be less extreme than suggested by individual studies and our pooled estimates for geographic strata. Although the incidence of BD has been much less studied, data from Asian and European populations also suggest more moderate geographic disparities, with 5-fold absolute differences in the incidence of BD [2] . A less extreme geographic gradient in BD prevalence reconciles the epidemiological data with the finding that 1952% of BD risk is attributable to HLA-B51 carriage [68] . Indeed, the differences in frequencies of HLA-B51 in general background populations, which grossly parallel the geospatial distribution of BD [69] , can explain, at most, moderate variations in BD risk across subpopulations.
Our study has limitations. Because of the relatively small number of studies, especially for some subgroup analyses, some results are prone to the effect of random error or lack of statistical power. In particular, the metaregression findings indicating BD prevalence significantly driven by study design but not geographic area could have resulted from low statistical power and should not lead to the conclusion that the reported geographic variations in the prevalence of BD are merely due to confounding. Also, the finding that between-study heterogeneity was not wholly explained by geographic area and study design leaves some uncertainty about other BD risk factors or study-specific confounders affecting BD prevalence.
To conclude, these findings shed a different light on understanding the geo-epidemiology of BD. By pinpointing methodological artefacts as a strong source of betweenstudy heterogeneity, they indicate that true variations in BD prevalence may be less prominent than suggested by estimates reported from individual studies and better align the geo-epidemiology data with the suspected high genetic burden of BD. The conceptual differences in findings generated by census vs sample surveys urge a differential interpretation of the meanings of the two approaches, especially if the latter involves screening for previously undiagnosed illness. These observations also highlight the general need for better standards of conducting and reporting studies describing the frequencies of diseases.
Funding: No specific funding was received from any bodies in the public, commercial or not-for-profit sectors to carry out the work described in this article.
Disclosure statement: The authors have declared no conflicts of interest. 
